Clinical potential of necitumumab in non-small cell lung carcinoma

Despite significant progress, new therapeutic approaches for advanced non-small cell lung cancer (NSCLC) are highly needed, particularly for the treatment of patients with squamous cell carcinoma. The epidermal growth factor receptor (EGFR) is often overexpressed in NSCLC and represents a relevant t...

Descripción completa

Detalles Bibliográficos
Autores principales: Genova, Carlo, Hirsch, Fred R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012835/
https://www.ncbi.nlm.nih.gov/pubmed/27621656
http://dx.doi.org/10.2147/OTT.S114039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012835/
https://www.ncbi.nlm.nih.gov/pubmed/27621656
http://dx.doi.org/10.2147/OTT.S114039

Ejemplares similares